Articles Referencing GILD

Zacks.com

Pipeline Progress at Gilead - Analyst Blog

Gilead Sciences, Inc. ( GILD ) recently presented encouraging data on its pipeline candidate idelalisib (formerly GS-1101) from a phase II study (study 101-08: n=64). The study is... Read >>

Zacks.com

Stock Market News for May 13, 2013 - Market News

Benchmarks finished in the green riding on positive investor sentiment. A few better-than-expected corporate results added to the prevailing optimism. Meanwhile, the Federal Reserve... Read >>

NASDAQ.com News

Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 14, 2013

Amgen Inc. ( AMGN ) will begin trading ex-dividend on May 14, 2013. A cash dividend payment of $0.47 per share is scheduled to be paid on June 07, 2013. Shareholders who purchased AMGN stock... Read >>

Minyanville

In Danish Laboratories, Hope Looms Large for a Permanent HIV Cure

So far HIV has eluded a permanent cure, yet many newly diagnosed patients can now control the virus with just one pill per day. Most lead relatively normal lives. In developing countries... Read >>

NASDAQ.com News

Techne Corporation (TECH) Ex-Dividend Date Scheduled for May 08, 2013

Techne Corporation ( TECH ) will begin trading ex-dividend on May 08, 2013. A cash dividend payment of $0.3 per share is scheduled to be paid on May 24, 2013. Shareholders who purchased TECH... Read >>

Minyanville

The Markets Now: Dow, S&P Hit New Highs on Employment Report

Stocks have climbed higher after nonfarm employment payrolls increased more than expected in April. The Dow (INDEXDJX:.DJI) reached a new intraday record, crossing above 15,000 for the first... Read >>

Zacks.com

Gilead Misses on Earnings, Sales in 1Q - Analyst Blog

Gilead Sciences, Inc. 's ( GILD ) first quarter 2013 earnings (excluding special items but including stock option expense) of 45 cents per share missed the Zacks Consensus Estimate of 47... Read >>

NASDAQ.com News

After-Hours Earnings Report for May 2, 2013 : GILD, AIG, CNQ, LNKD, MYL, WFT, FLR, XL, TDC, MHK, MCHP, CPT

The following companies are expected to report earnings after hours on 05/02/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Gilead Sciences, Inc. ( GILD )... Read >>

Minyanville

The Markets Now: Stocks Climb Higher After ECB Rate Cut, Jobless Claims Report

Stocks have rebounded after closing lower yesterday. The European Central Bank lowered its refinancing rate to 0.50% from 0.75% to help the continent's banking system. New weekly unemployment... Read >>

Benzinga

Benzinga Market Primer: Thursday, May 2

Futures Higher On Central Banks U.S. equity futures rose slightly in early pre-market trade following the FOMC saying that it is prepared to increase or decrease asset purchases depending on the... Read >>

Zacks.com

Double Setback for Gilead - Analyst Blog

Gilead Sciences, Inc ( GILD ) suffered two successive setbacks when the US Food and Drug Administration (FDA) issued complete response letters (CRLs) to the company's HIV candidates,... Read >>

Benzinga

A Look Ahead: This Week's ETFs to Watch

Last week was another fine one for U.S. stocks as the broader market fought off an array of data points that can only be considered mixed at best to again close higher. With last week's 1.4... Read >>

NASDAQ.com News

After Hours Most Active for Apr 26, 2013 : STX, CMCSA, BAC, NTAP, VZ, QQQ, GILD, INTC, APC, GE, AXP, PFE

The NASDAQ 100 After Hours Indicator is down -.12 to 2,840.43. The total After hours volume is currently 35,787,077 shares traded. The following are the most active stocks for the after... Read >>

Minyanville

Buzz on the Street: Apple Earnings, a Hijacked AP, and the Telltale VIX Make for One Wacky Week

All day and every day, some of the stock market's best and brightest traders and money managers share their ideas, insights, and analysis in real-time on Minyanville's Buzz & Banter. ... Read >>

Zacks.com

Is the Biotech Sector Still a Market Leader? - Real Time Insight

The biotechnology sector has been a strong performer for much of 2013. The space has seen huge gains over and above that of the broad market, with biotech benchmarks outpacing the S&P... Read >>

Displaying 1-15 of 128
<< first < previous 1 2 3 4 5 6 7 8 9 next > last >>